Tag: GSK
Aurobindo Pharma to manufacture, supply long-acting HIV treatment drug
Hyderabad-based Aurobindo Pharma has been selected as one of the generic manufacturers under the expanded voluntary licensing agreement between the Medicines Patent Pool (MPP)...
Johnson & Johnson becomes the world’s most valuable pharma brand for...
Johnson & Johnson has claimed the title of the world's most valuable and strongest pharmaceutical brand, according to a new report by Brand Finance, the world’s leading...
The modernization of the Perfect Containers Group
Founded almost 40 years ago, the Perfect Containers Group is a family-owned and managed business, headquartered in Mumbai with seven manufacturing plants for tubes...
Sanofi, GSK in discussion to supply 300 million doses of Covid-19...
Sanofi and GSK are in advanced discussions with the European Commission (EC) for the supply of up to 300 million doses of a Covid-19...
GSK begins Covid-19 vaccine clinical trials with Clover
GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted Covid-19 vaccine has entered into human clinical trials. Clover announced the initiation of phase...
Covid-19 vaccine – When will we have it?
The recognized Covid-19 cases have surpassed 6.3 million globally and continue to grow. While the world is eagerly waiting for the coronavirus vaccine, research...
GSK to produce 1 billion doses of vaccine adjuvant in 2021
GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted...
GSK’s Zejula gets FDA approval to treat women with platinum-responsive advanced...
GlaxoSmithKline announced the US Food and Drug Administration (FDA) approved the company’s supplemental New Drug Application (sNDA) for Zejula (niraparib), an oral, once-daily poly...
Sanofi and GSK collaborate to develop COVID-19 vaccine
Sanofi and GSK announced that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19,...